Five Life Sciences Companies Ramping up the Fall Flood of IPOs

Experts are predicting a record-breaking rush of IPOs this fall as companies flood to the Nasdaq. Here’s who’s ready to go public in the life science industry today.

Driven by the power of AI, the U.K.’s Exscientia is a pioneer in automated drug design. With three AI-designed candidates making history as the first to enter human clinical trials, the company is ready to leave VC funding behind and hit the open market. Exscientia filed for a U.S. IPO with SEC Friday, utilizing the popular $100 million placeholder.